Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass Sudip Ghosh, MD, Manuel Galiñanes,

Slides:

Advertisements

Similar presentations

Chris A. Rogers, PhD, Alan J

Advertisements

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Manuel J. Antunes, MD, PhD, DSc

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Controlled reoxygenation during cardiopulmonary bypass decreases markers of organ damage, inflammation, and oxidative stress in single-ventricle patients.

David W. Barbara, MD, William J. Mauermann, MD, James R

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N

Intraoperative bypass graft flow in intra-aortic balloon pump–supported patients: Differences in arterial and venous sequential conduits Francesco Onorati,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades Jeanne Shen, BS, Shelly Lall,

Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial.

Bone marrow cell–induced protection of the human myocardium: Characterization and mechanism of action Vien Khach Lai, MD, José Linares-Palomino, MD,

Cold-induced fluid extravasation during cardiopulmonary bypass in piglets can be counteracted by use of iso-oncotic prime Marit Farstad, MD, Venny Lise.

Long-term outcomes of coronary artery bypass grafting patients supported preoperatively with an intra-aortic balloon pump Eli Hemo, MD, Benjamin Medalion,

Chris A. Rogers, PhD, Alan J

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass Ying-jie Sun, PhD, Dan-dan Song,

Sequela-free long-term survival of a 65-year-old woman after 8 hours and 40 minutes of cardiac arrest from deep accidental hypothermia Marie Meyer, MD,

Defining operative mortality: Impact on outcome reporting

Cardiac troponin I release after open heart surgery: a marker of myocardial protection? Emmanuelle Vermes, MD, Martine Mesguich, MD, Rémi Houel, MD, Céline.

The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.

Steven R. Gundry, MD, Matthew A. Romano, MD, O

Multilevel data analysis: What? Why? How?

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Late remote ischemic preconditioning in children undergoing cardiopulmonary bypass: A randomized controlled trial Marcos A. Pavione, MD, Fabio Carmona,

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve.

One single dose of histidine–tryptophan–ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive.

Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during.

Myocardial metabolic changes during pediatric cardiac surgery: A randomized study of 3 cardioplegic techniques P. Modi, FRCS, M.-S Suleiman, PhD, B Reeves,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Volume 87, Issue 2, Pages (February 2015)

Jonathan C. Nesbitt, MD, Nicole M

Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study Yves A.G Louagie, MD, PhD, Jacques Jamart, MD, Manuel.

Endothelin-1 during and after cardiopulmonary bypass: Association to graft sensitivity and postoperative recovery Brian R. Bond, PhD, B.Hugh Dorman,

For everything there is a season

Michele Gallo, MD, Gino Gerosa, MD

Niv Ad, MD, Sari D. Holmes, PhD, Paul S. Massimiano, MD, Anthony J

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing.

Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures Yasir Abu-Omar, MRCS, Lognathen Balacumaraswami,

Guidelines should bother us, not comfort us

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Kai Ihnken, MD The Journal of Thoracic and Cardiovascular Surgery

Insulin cardioplegia for elective coronary bypass surgery

Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery Bryan M. Burt, MD, Andrew W. ElBardissi, MD,

Shengshou Hu, MD, Xin Yuan, MD, PhD

Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting Zhong-Kai Wu, MD, Matti R Tarkka,

Adenosine-enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia James D McCully, PhD, Masahisa Uematsu,

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Cardiac surgery during pregnancy: pulsatile or nonpulsatile perfusion?

Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: Clinical experience with 1400 cases Yves Durandy, MD, Sylvie.

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations Zhong-Kai Wu, MD, PhD, Jari Laurikka, MD, PhD, Antti Saraste, MD, PhD, Ville.

Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and.

Elevated flow rate during cardiopulmonary bypass is associated with fluid accumulation Oddbjørn Haugen, MD, Marit Farstad, MD, PhD, Venny Kvalheim, MD,

Competitive flow in coronary bypass surgery: The roles of fractional flow reserve and arterial graft configuration Hugh S. Paterson, FRACS, Paul G. Bannon,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery Yoshiya Toyoda, MD, Masahiro Yamaguchi,

Roderick W Landymore, MD, Alexander J Bayes, MD, J

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Analysis of the learning curve for beating heart, totally endoscopic, coronary artery bypass grafting Nan Cheng, MD, Changqing Gao, MD, Ming Yang, MD,

Comparing microvascular alterations during minimal extracorporeal circulation and conventional cardiopulmonary bypass in coronary artery bypass graft.

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa.

Presentation transcript:

Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass Sudip Ghosh, MD, Manuel Galiñanes, MD, PhD, FRCS The Journal of Thoracic and Cardiovascular Surgery Volume 126, Issue 1, Pages 133-142 (July 2003) DOI: 10.1016/S0022-5223(02)73293-5

Figure 1A Time course of release of plasma cardiac troponin T (TnT) concentrations in patients undergoing coronary artery bypass grafting with CPB and aortic crossclamping. In each group, patients were randomly subdivided into control and preconditioning groups (n = 20/group). Data are expressed as mean ± SD (*P < .05 vs control group). Time course of release of plasma cardiac TnT concentrations in patients undergoing coronary artery bypass grafting with CPB and cold blood cardioplegia (B) and on the beating heart without CPB (C). In each group, patients were randomly subdivided into control and preconditioning groups (n = 20/group). Data are expressed as mean ± SD (*P < .05 vs control group). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 133-142DOI: (10.1016/S0022-5223(02)73293-5)

Figure 1A Time course of release of plasma cardiac troponin T (TnT) concentrations in patients undergoing coronary artery bypass grafting with CPB and aortic crossclamping. In each group, patients were randomly subdivided into control and preconditioning groups (n = 20/group). Data are expressed as mean ± SD (*P < .05 vs control group). Time course of release of plasma cardiac TnT concentrations in patients undergoing coronary artery bypass grafting with CPB and cold blood cardioplegia (B) and on the beating heart without CPB (C). In each group, patients were randomly subdivided into control and preconditioning groups (n = 20/group). Data are expressed as mean ± SD (*P < .05 vs control group). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 133-142DOI: (10.1016/S0022-5223(02)73293-5)

Figure 2 Area under the curve of the plasma release cardiac TnT in patients undergoing coronary artery bypass grafting with CPB and aortic crossclamping, CPB and cold blood cardioplegia, and on the beating heart without CPB (*P < .05 vs corresponding control group). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 133-142DOI: (10.1016/S0022-5223(02)73293-5)

Figure 3 CK leakage (A) during the 120-minute reoxygenation period and MTT reduction (B) at the end of the reoxygenation period after 90 minutes of normothermic global ischemia with or without simulated IP. Data are expressed as mean ± SD of 6 experiments (*P < .05 vs corresponding group without preconditioning). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 133-142DOI: (10.1016/S0022-5223(02)73293-5)